[Form 4] Health In Tech, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Insider transactions by director William D. Howard at Health In Tech, Inc. (HIT)

The reporting person, a director, disposed of 28,159 restricted shares of Class A common stock that were subject to pro-rata forfeiture upon the annual stockholders meeting held on 10/03/2025. Five days later, on 10/08/2025, the director acquired 5,730 restricted shares at a price of $3.49 per share under the company’s Equity Incentive Plan. After these transactions the director beneficially owns 106,045 shares of Class A common stock.

Positive

• Purchased 5,730 shares at $3.49, increasing beneficial ownership to 106,045 shares
• Acquisition executed under the Equity Incentive Plan, indicating alignment with company compensation structure

Negative

• Disposed of 28,159 restricted shares due to forfeiture tied to the annual stockholders meeting on 10/03/2025

Insights

Corporate Governance Analyst

Director converted forfeitable awards and modestly increased reported holdings.

The director’s 10/03/2025 disposal reflects forfeiture tied to the annual meeting mechanism, not an open-market sale, and the subsequent 10/08/2025 purchase of 5,730 restricted shares at $3.49 increases the reported beneficial stake to 106,045 shares.

This pattern is consistent with equity compensation vesting and plan activity; monitor upcoming vesting schedules and any additional Form 4s within the next quarter for changes to beneficial ownership.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Howard William D.

(Last) (First) (Middle)

701 S. COLORADO AVE

SUITE 1

(Street)

STUART FL 34994

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Health In Tech, Inc. [ HIT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	10/03/2025		D		28,159(1)	D	$0	100,315	D
Class A Common Stock	10/08/2025		A		5,730(2)	A	$3.49	106,045(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan, which were subject to forfeiture on a pro-rata basis upon the issuer's annual stockholders meeting held on October 3, 2025.

2. Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vest quarterly commencing upon the date of grant, subject to the reporting person's continuous service through the vesting date.

3. Includes 5,730 shares of restricted stock and 100,315 shares of Class A Common Stock.

	By William D. Howard /s/ William D. Howard	10/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did William D. Howard report for HIT?

He reported a disposal of 28,159 restricted Class A shares on 10/03/2025 and an acquisition of 5,730 restricted shares on 10/08/2025 at $3.49 per share.

How many HIT shares does the reporting person beneficially own after the transactions?

The reporting person beneficially owns 106,045 shares of Class A common stock following the reported transactions.

Were the transactions open-market trades or plan-based?

The filings state the shares were granted and acquired pursuant to the Health In Tech Equity Incentive Plan, and the disposal related to forfeiture tied to the annual meeting.

What caused the disposal of 28,159 shares?

Those shares were restricted and subject to pro-rata forfeiture upon the issuer’s annual stockholders meeting held on 10/03/2025.

Did the Form 4 indicate joint filing or multiple reporting persons?

The Form 4 was filed by one reporting person according to the filing.